Jack W. Callicutt
2018
In 2018, Jack W. Callicutt earned a total compensation of $1.3M as Chief Financial Officer at Galectin Therapeutics, a 212% increase compared to previous year.
Compensation breakdown
| Bonus | $213,750 |
|---|---|
| Option Awards | $715,319 |
| Salary | $275,278 |
| Other | $62,150 |
| Total | $1,266,497 |
Callicutt received $715.3K in option awards, accounting for 56% of the total pay in 2018.
Callicutt also received $213.8K in bonus, $275.3K in salary and $62.2K in other compensation.
Rankings
In 2018, Jack W. Callicutt's compensation ranked 8,014th out of 14,244 executives tracked by ExecPay. In other words, Callicutt earned more than 43.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,014 out of 14,244 | 44th |
Division Manufacturing | 3,153 out of 5,759 | 45th |
Major group Chemicals And Allied Products | 1,175 out of 2,122 | 45th |
Industry group Drugs | 987 out of 1,811 | 46th |
Industry Pharmaceutical Preparations | 766 out of 1,385 | 45th |
Source: SEC filing on October 19, 2020.
Callicutt's colleagues
We found one more compensation record of an executive who worked with Jack W. Callicutt at Galectin Therapeutics in 2018.
2018
Harold Shlevin
Galectin Therapeutics